Abstract
Rabies is an acute central nervous system (CNS) disease of mammals that almost invariably results in death. Disease develops following productive infection with a bullet-shaped, enveloped virus that contains single-stranded, nonsegmented, negative-sense RNA.(169) Rabies virus is the type species of the Lyssavirus genus, family Rhabdoviridae. In the usual scheme of pathogenesis, virus gains entry to the host body via the bite of a rabid animal. Historically in the United States, the primary source of human exposure was the domestic dog, which still predominates as the major reservoir in developing countries. Now, wildlife are primarily affected in developed countries: current rabies reservoirs in the United States include raccoons, skunks, foxes, coyotes, and bats.(88) The incubation period in humans is variable, from <10 days to > 6 years, but usually on the order of 4–6 weeks following an animal bite.(136) During the incubation period, virus is nearly undetectable and may replicate locally in muscle tissue at the initial site of entry.(34,35) Alternatively, virus may proceed directly and centripetally through the axoplasm of peripheral nerves to the CNS. Once in the nervous system, virus replicates and spreads quickly,(127) with associated dysfunctional clinical signs partially dependent on the affected area and relative severity of infection. Overt disease is initially nonspecific, consisting of signs and symptoms in humans compatible with a “flulike illness,” such as fever, headache, and general malaise. Following the prodromal stage, an acute neurological phase may include intermittent insomnia, anxiety, confusion, paresis, percussion myoedema, excitation, agitation, hallucinations, cranial nerve deficits, chorea, dysphagia, hypersalivation, piloerection, priapism, paralysis, and sometimes maniacal behavior.(75) Clinical presentation may also include classic symptoms of paresthesia at the site of bite exposure and hydrophobia (a synonymous term for the human disease)(57) or aerophobia manifesting as phobic pharyngeal spasms following provocative stimuli. The clinical course is acute, with death usually ensuing within days. A form of the disease termed “dumb rabies” may also present as part of the clinical spectrum, with the general sparing of consciousness together with ascending paralysis, progressive unresponsiveness, coma, and death. Once clinical signs are present, there is no cure. Intensive medical support may prolong life, but ultimately death ensues. Exceptions to this are exceedingly rare with only four well-documented cases of human survival from clinical rabies (all with a history of either pre- or postex-posure therapy).(1,23,73,109) Two of the four survivors have significant residual neurological impairment. Acquired immunity in the rabies vector species, presumably following subclinical exposure, abortive infection, or survival of overt clinical rabies, is apparently rare, but lias been supported to an extent by serological surveys of wildlife and documented occurrences under laboratory conditions.(50,54)
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Alvarez, L., Fajardo, R., Lopez, E., Pedroza, R., Hemachuda, T., Kamolvarin, N., Cortes, G., And Baer, G., Partial recovery from rabies in a nine-year-old boy, Pediatr. Infect. Dis. J. 13: 1154–1155 (1994).
Artois, M., Aubert, M., And Blancou, J., Behavioral ecology of the transmission of rabies, Ann. Rech. Vet. 22: 163–172 (1991).
Aubert, M., Blancou, J., Barrat, J., Artois, M., And Barrat, M. J., Transmission and pathogenesis of two rabies isolates from the red fox at a 10 year interval, Ann. Rech. Vet. 22: 77–93 (1991).
Aubert, M., Control of rabies in foxes: What are the appropriate measures? Vet. Rec. 134: 55–59 (1994).
Aubert, M., Masson, E., Artois, M., And Barrat, J., Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France, Curr. Topics Microbiol. Immun. 187: 219–243 (1994).
Baer, G. M., Animal models in the pathogenesis and treatment of rabies, Rev. Infect. Dis. 10: 5739–750 (1988).
Baer, G. M., Rabies-an historical perspective, Infect. Agents Dis. 3: 168–180 (1994).
Baer, G. M., Shaddock, J. H., Quirion, R., Dam, T. V., And Lentz, T. L., Rabies susceptibility and the acetylcholine receptor, Lancet 335: 664–665 (1990).
Barnard, B. J. H., And Voges, S. I., A simple technique for the rapid diagnosis of rabies in formalin-fixed brain, Onderstepoort J. Vet. Res. 49: 193–194 (1982).
Balachandran, A., And Charlton, K., Experimental rabies infection of non-nervous tissues in skunks (Mephitis mephitis) and foxes (Vulpes vulpes), Vet. Pathol. 31: 93–102 (1994).
Bingham, J., Foggin, C. M., Gerber, H., Hill, F. W., Kap-Peler, A., King, A. A., Perry, B. D., And Wandeler, A. I., Pathogenicity of Sad rabies vaccine given orally in chacma baboons (Papio ursinus), Vet. Rec. 131: 55–56 (1992).
Black, D., And Wiktor, T. J., Survey of raccoon hunters for rabies antibody titers: Pilot study, J. Fla. Med. Assoc. 73: 517–520 (1986).
Blancou, J., Kieny, M. P., Lathe, R., Lecocq, J. P., Pastoret, P. P., Soulebot, J. P., And Desmettre, P., Oral vaccination of the fox against rabies using a live recombinant vaccinia virus, Nature 332: 373–375 (1986).
Blancou, J., Baltazar, R. S., Molli, I., And Stoltz, J. F., Effective postexposure treatment of rabies-infected sheep with rabies immune globulin and vaccine, Vaccine 9: 432–437 (1991).
Bourgon, A. R., And Charlton, K. M., The demonstration of rabies antigen in paraffin-embedded tissues using the peroxidaseantiperoxidase method: a comparative study, Can. J. Vet. Res. 51: 117–120 (1986).
Bourhy, H., KIssI, B., Lafon, M., Sacramento, D., And Tordo, N., Antigenic and molecular characterization of bat rabies virus in Europe, J. Clin. Microbiol. 30: 2419–2426 (1992).
Bourhy, H., Kiss’, B., And Tordo, N., Molecular diversity of the lyssavirus genus, Virology 194: 70–78 (1993).
Boyle, D. B., Disease and fertility control in wildlife and feral animal populations: Options for vaccine delivery using vectors, Reprod. Fertil. Dey. 6: 393–400 (1994).
Briggs, D. J., And Schwenke, J. R., Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine, Vaccine 10: 125–129 (1992).
Brochier, B., KiElsrv, M. P., Costy, E, Coppens, P., Bauduin, B., Lecocq, J. P., Languet, B., Chappuis, G., Desmettre, E, Afiademanyo, K., Libois, R., And Pastoret, D.-P., Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine, Nature 354: 520–522 (1991).
Cadoz, M., Strady, A., Meignier, B., Taylor, J., Tartaglia, J., Paoletti, E., And Plotkin, S., Immunisation with canarypox virus expressing rabies glycoprotein, Lancet 339: 1429–1432 (1992).
Celis, E., Rupprecht, C. E., And Plotkin, S. A., New and improved vaccines against rabies, in: New Generation Vaccines (G. C. Woodrow And M. M. Levine, Eds.), pp. 419–438, Marcel Dekker, New York, 1990.
Centers For Disease Control, Rabies in a laboratory worker-New York, Morbid. Mortal. Week. Rep. 26: 183–184 (1977).
Centers For Disease Control, Human rabies-Kenya, Morbid. Mortal. Week. Rep. 32: 494–495 (1983).
Centers For Disease Control, Rabies prevention-United States, 1991, Morbid. Mortal. Week. Rep. 40 (RR-3): 1–19 (1991).
Centers For Disease Control, Human rabies-New York, 1993, Morbid. Mortal. Week. Rep. 42: 799–806 (1993).
Centers For Disease Control, Human rabies-Texas and California, 1993, Morbid. Mortal. Week. Rep. 43: 93–96, 1994.
Centers For Disease Control, Raccoon rabies epizootic-United States, 1993, Morbid. Mortal. Week. Rep. 43: 269–273 (1994).
Centers For Disease Control, Human rabies-California, 1994, Morbid. Mortal. Week. Rep. 43: 455–458 (1994).
Centers For Disease Control, Human rabies-Miami, 1994, Morbid. Mortal. Week. Rep. 43: 773–775 (1994).
Centers For Disease Control, Human rabies-West Virginia, 1994, Morbid. Mortal. Week. Rep. 44: 86–87 (1994).
Centers For Disease Control, Compendium of animal rabies control, 1995, Morbid. Mortal. Week. Rep. 44 (RR-2): 1–9 (1995).
Centers For Disease Control, Human rabies-Alabama, Tennessee and Texas, 1994, Morbid. Mortal. Week. Rep. 44: 269272 (1995).
Charlton, K. M., The pathogenesis of rabies and other lyssaviral infections: Recent studies, Curt: Topics Microbiol. Immun. 187: 95–119 (1994).
Charlton, K. M., Webster, W. A., And Casey, G. A., Skunk rabies, in: Natural History of Rabies, 2nd ed. (G. M. Baer, ED.), pp. 307–324, Crc Press, Boca Raton, FL, 1991.
Charlton, K. M., Artois, M., Prevec, L., Campbell, J. B., Casey, G. A., Wandeler, A. I., And Armstrong, J., Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine, Arch. Virol. 123: 169–179 (1992).
Cherkasskiy, B. L., Roles of the wolf and the raccoon dog in the ecology and epidemiology of rabies in the Ussr, Rev. Infect. Dis. 10 (Suppl. 4): S634–636 (1988).
Cheung, S. C., Dietzschold, B., Koprowski, H., Notkins, A. L., And Rando, R. F., A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus, J. Virol. 66: 6714–6720 (1992).
Cho, H. C., And LAwsoN, K. E, Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyperimmune globulin (human), Can. J. Vet. Res. 53: 434–437 (1989).
Clark, K. A., Neill, S. U., Smith, J. S., Wilson, P. J., WhadfoRD, V. W., And Mckirahan, G. W., Epizootic canine rabies transmitted by coyotes in south Texas, J. Am. Vet. Med. Assoc. 204: 536–540 (1994).
Dietzschold, B., Wang, H., Rupprecht, C. E., Cells, E., Tollis, M., Ertl, H., Heber-Katz, E., And Koprowski, H., Induction of protective immunity against rabies by immunization with rabies virus nucleoprotein, Proc. Natl. Acad. Sci. Usa 84: 9165–9169 (1987).
Dietzschold, B., Tollis, M., Rupprecht, C. E., Cells, E., And Koprowski, H., Antigenic variation in rabies and rabies-related viruses: Cross-protection independent of glycoprotein-mediated virus-neutralizing antibody, J. Infect. Dis. 156: 815–822 (1987).
Dietzschold, B., Rupprecht, C. E., Tollis, M., Lafon, M., Mattei, J., Wiktor, T. J., And Koprowski, H., Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: Implications for epidemiology and control of rabies, Rev. Infect. Dis. 10 (Suppl. 4): S785–798 (1988).
Dietzschold, B., Gore, M., Casali, P, Ueki, Y., Rupprecht, C. E., Notkins, A. L., And Koprowski, H., Biological characterization of human monoclonal antibodies to rabies virus, J. Virol. 64: 3087–3090 (1990).
Dietzschold, B., Kao, M., Zheng, Y. M., Chen, Z. Y., Maul, G., Fu, Z. E, Rupprecht, C. E., And Koprowski, H., Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system, Proc. Natl. Acad. Sci. Usa 89: 7252–7256 (1992).
Enssle, K., Kurrle, R., Kohler, R., Muller, H., Kanzy, E. J., Hileenhaus, J., And Seiler, E. R., A rabies-specific human monoclonal antibody that protects mice against lethal rabies, Hybridoma 10: 547–556 (1991).
Esposito, J. J., Knight, J. C., Shaddock, J. H., Novembre, E. J., And Baer, G. M., Successful oral vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus gly- coprotein, Virology 165: 313–316 (1988).
Everard, C. O., And Everard, J. D., Mongoose rabies in the Caribbean, Ann. N.Y. Acad. Sci. 653: 356–366 (1992).
Feidon, W., Kalser, E, Gerhard, L., Dahme, E., Gylstroff, B., Wandeler, A., And Ehrensberger, E, Immunohistochemical staining of rabies virus antigen with monoclonal and polyclonal antibodies in paraffin tissue section, Zentralbi. Vet. Med. 35: 247–258 (1988).
Fekadu, M., Latency and aborted rabies, in: The Natural History of Rabies, 2nd ed. (G. M. Baer, ED.), pp. 191–200, Crc Press, Boca Raton, FL, 1991.
Fekadu, M., Greer, P. W., Chandler, E W., And Sanderlin, D. W., Use of the avidin-biotin peroxidase system to detect rabies antigen in formalin-fixed paraffin-embedded tissues, J. Virol. Methods 19: 91–96 (1988).
Fekadu, M., Shaddock, J. H., Sumner, J. W., Sanderlin, D. W., Knight, J. C., Esposito, J. J., And Baer, G. M., Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein, J. Wildl. Dis. 27: 681–684 (1991).
Fekadu, M., Shaddock, J. H., Ekstrom, J., Osterhaus, A., Sanderlin, D. W., Sundquist, B., And Morein, B., An immune stimulating complex (Iscom) subunit rabies vaccine protects dogs and mice against street rabies challenge, Vaccine 10: 192–197 (1992).
Fekadu, M., Summer, J. W., Shaddock, J. H., Sanderlin, D. W., And Baer, G. M., Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein, J. Virol. 66: 2601–2604 (1992).
Fishbein, D., Belotto, A. J., Pacer, R. E., Smith, J. W., Winkler, W. G., Jenkins, S. R., And Porter, K. M., Rabies in rodents and lagomorphs in the United States, 1971–1984: Increased cases in the woodchuck (Marmota monax) in mid-Atlantic States, J. Wildl. Dis. 22: 151–155 (1986).
Fishbein, D. B., Yenne, K. M., Dreesen, D. W., Teplis, C. F., Mehta, N., And Briggs, D. J., Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: A nationwide prospective study, Vaccine 11: 1390–1394 (1993).
Fleming, G., Rabies and Hydrophobia, Chapman and Hall, London, 1872.
Fogelman, V., Fischman, H. R., Horman, J. T., And Grigor, J. K., Epidemiologic and clinical characteristics of rabies in cats, J. Am. Vet. Med. Assoc. 202: 1829–1833 (1993).
Follmann, E. H., Ritter, D. G., And Beller, M., Survey of fox trappers in northern Alaska for rabies antibody, Epidemiol. Infect. 113: 137–140 (1994).
Frontini, M. G., Fishbein, D. B., Garza, R. J., Flores Col-Lins, E., Baldaret Torres, J. M., Quiret Huerta, G., Gamez Roriguez, J. J., Belotto, A. J., Dobbins, J. G., Linhart, S. B., And Baer, G. M., A field evaluation in Mexico of four baits for oral rabies vaccination of dogs, Am. J. Trop. Med. Hyg. 47: 310–316 (1992).
Fu, Z. F., Rupprecht, C. E., Dietzschold, B. D., Saikumar, P., NIu, H. S., Babka, I., Wunner, W. H., And Koprowski, H., Oral vaccination of raccoons (Procyon lotor) with baculo-virus- expressed rabies virus glycoprotein, Vaccine 11: 925–928 (1993).
Fu, Z. F., Weihe, E., Zheng, Y. M., Schafer, M. K., Sheng, H., Corisdeo, S., Rauscher, E J., Koprowski, H. K., And Dietzschold, B., Differential effects of rabies and borna disease viruses on immediate-early-and late-response gene expression in brain tissues, J. Virol. 67: 6674–6681 (1993).
Gascoyne, S. C., Laurenson, M. K., Lelo, S., And Borner, M., Rabies in African wild dogs (Lycaon pictus) in the Serengeti region, Tanzania, J. Wildl. Dis. 29: 396–402 (1993).
Goldwasser, R. A., And Kissling, R. E., Fluorescent antibody staining of street and fixed rabies virus antigens, Proc. Soc. Exp. Biol. Med. 98: 219–223 (1958).
Gosztonyi, G., Dietzschold, B., Kao, M., Rupprecht, C. E., And Koprowski, H., Rabies and borna disease: A comparative pathogenetic study of two neurovirulent agents, Lab. Invest. 68: 285–295 (1993).
Haddad, N., Ben Khelifa, R., Matter, H., Kharmachi, H., Aubert, M. F., Wandeler, A., And Blancou, J., Assay of oral vaccination of dogs against rabies in Tunisia with the vaccinal strain Sadbern, Vaccine 12: 307–309 (1994).
Hamir, A. N., And Moser, G., Immunoperoxidase test for rabies: Utility as a diagnostic test, J. Vet. Diagn. Invest. 6: 148–152 (1994).
Hanlon, C. A., Ziemer, E. L., Hamir, A. N., And Rupprecht, C. E., Cerebrospinal fluid analysis of rabid and vaccinia-rabies glycoprotein recombinant, orally vaccinated raccoons (Procyon lotor), Am. J. Vet. Res. 50: 364–367 (1989).
Hanlon, C. A., Hayes, D. E., Hamir, A. N., Snyder, D. E., Jenkins, S., Hable, C. P., And Rupprecht, C. E., Proposed field evaluation of a rabies recombinant vaccine for raccoons (Procyon lotor): Site selection, target species characteristics, and placebo baiting trials, J. Wildl. Dis. 25: 555–567 (1989).
Hanlon, C. A., Buchanan, J. R., Nelson, E., Niu, H. S., Diehl, D., And Rupprecht, C. E., A vaccinia-vectored rabies vaccine field trial: Ante-and post-mortem biomarkers, Rev. Sci. Tech. 12: 99–107 (1993).
Hanlon, C. A., And Rupprecht, C. E., Considerations for immunocontraception among free-ranging carnivores: The rabies paradigm, in: Contraception in Wildlife Management (T. J. Kreeger, ED.), US Government Printing Office, Washington, DC, in press.
Hasemann, C. A., And Capra, J. C., High level production of a functional immunoglobulin in a baculovirus expression system, Proc. Natl. Acad. Sci. Usa 87: 3942–3946 (1990).
Hattwick, M. A. W., Weis, T. T., Stechschulte, J., Baer, G. M., And Gregg, M. B., Recovery from rabies: A case report, Ann. Intern. Med. 76: 931–942 (1972).
Helmick, C. G., Tauxe, R. V., And Vernon, A. A., Is there a risk to contacts of patients with rabies? Rev. Infect. Dis. 9: 511–518 (1987).
Hemachuda, T., Human rabies: Clinical aspects, pathogenesis, and potential therapy, in: Lyssaviruses (C. E. Rupprecht, B. Dietzschold, And H. Koprowski, Eds.), pp. 121–143, Springer-Verlag, New York, 1994.
Hill, R. E., Beran, G. W., And Clark, W. R., Demonstration of rabies virus-specific antibody in the sera of free-ranging Iowa raccoons (Procyon lotor), J. Wildl. Dis. 28: 377–385 (1992).
Hill, R. E., And Beran, G. W., Experimental inoculation of raccoons (Procyon lotor) with rabies virus of skunk origin, J. Wildl. Dis. 28: 51–56 (1992).
78. Hill, R. E. Smith, K. E., Beran, G. W., And Beard, P. D., Further studies on the susceptibility of raccoons (Procyon lotor) to a rabies virus of skunk origin and comparative susceptibility of striped skunks (Mephitis mephitis), J. Wildl. Dis. 29:475–477 (1993).
Jackson, A. C., Reimer, D. L., And Ludwin, S. K., Spontaneous recovery from the encephalomyelitis in mice caused by street rabies virus, Neuropathol. Appl. Neurobiol. 15: 459–475 (1989).
Johnson, K. P., Swoveland, P. T., And Emmons, R. W., Diagnosis of rabies by immunofluorescence in trypsin-treated histologic sections, J.A.M.A. 244: 41–43 (1980).
Johnston, D. H., Voight, D. R., Macinnes, C. D., Bachmann, P., Lawson, K. F., And Rupprecht, C. E., An aerial baiting system for the distribution of attenuated or recombinant rabies vaccines for foxes, raccoons and skunks, Rev. Infect. Dis. 10: S660–664 (1988).
Kamolvarin, N., Tirawatnpong, T., Rattanasiwamoke, R., Tirawatnpong, S., Panpanich, T., And Hemachuda, T., Diagnosis of rabies by polymerase chain reaction with nested primers, J. Infect. Dis. 167: 207–210 (1993).
Kharmachi, H., Haddad, N., And Matter, H., Tests of four baits for oral vaccination of dogs against rabies in Tunisia, Vet. Rec. 130: 494 (1992).
Kieny, M. P., Lathe, R., Drillien, R., Spehner, D., Skory, S., Schmitt, D., Wiktor, T. J., Koprowski, H., And Lecocq, J. P., Expression of the rabies virus glycoprotein from a recombinant vaccinia virus, Nature 312: 163–166 (1984).
King, A., Dames, P., And Lawrie, A., The rabies viruses of bats, Vet. Microbiol. 23: 165–174 (1990).
King, A. A., Meredith, C. D., And Thomson, G. R., The biology of Southern African lyssavirus variants, Curt: Topics Microbiol. Immun. 187: 267–295 (1994).
Klepfer, S. R., Debouck, C., Uffelman, J., Jacobs, P., BoLlen, A., And Jokes, E. V., Characterization of rabies glycoprotein expressed in yeast, Arch. Virol. 128: 269–286 (1993).
Koprowski, H., Zheng, Y. M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z. E, Hanlon, C., And Dietzschold, B., In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases, Proc. Natl. Acad. Sci. Usa 90: 3024–3027 (1993).
Krebs, J. W., Strine, T. W., Smith, J. S., Rupprecht, C. E., And Childs, J. E., Rabies surveillance in the United States during 1994, J. Am. Vet. Med. Assoc. 207: 1562–1575. (1995).
Lafay, E, Benejean, J., Tuffereau, C., Flamand, A., And Coulon, P., Vaccination against rabies: Construction and characterization of Sag2, a double avirulent derivative of Sadbern, Vaccine 12: 317–320 (1994).
Lafon, M., And Lafage, M., Antiviral activity of monoclonal antibodies specific for the internal proteins of N and NS of rabies virus, J. Gen. Virol. 68: 3113–3123 (1987).
Lafon, M., Edelman, L., Bouvet, J. P., Lafage, M., And Montchatre, E., Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein, J. Gen. Virol. 71: 16891696 (1990).
Lafon, M., Lafage, M., Martinez-Arends, A., Ramirez, R., Vuillier, F., Charron, D., Lotteau, V., And Scott-Algara, D., Evidence for a viral superantigen in humans, Nature 358: 607–610 (1992).
Lawson, K. F., Johnston, D. H., Patterson, J. M., Hertler, R., Campbell, J. B., And Rhodes, A. J., Immunization of foxes by the intestinal route using an inactivated rabies vaccine, Can. J. Vet. Res. 53: 56–61 (1989).
Linhart, S. B., Blom, F. S., Dasch, G. J., Roberts, J. D., Engeman, R. M., Esposito, J. J., Shaddock, J. H., And Baer, G. M., Formulation and evaluation of baits for oral rabies vaccination of raccoons (Procyon lotor), J. Wildl. Dis. 27: 21–33 (1991).
Linhart, S. B., Creekmore, T. E., CoRN, J. L., Whitney, M. D., Snyder, B. D., And Nettles, V. F., Evaluation of baits for oral rabies vaccination of mongooses: Pilot field trials in Antigua, West Indies, J. Wildl. Dis. 29: 290–294 (1993).
Lopez, A., Miranda, R, Tejada, E., And Fishbein, D. B., Outbreak of human rabies in the Peruvian jungle, Lancet 339: 408–411 (1992).
Mallory, L. B., Campaign against rabies in Modoc and Lassen Counties, Calif. State Board Health Monthly Bull. 11: 273–277 (1915).
Mccoll, K. A., Gould, A. R., Selleck, P. W., Hooper, R T., Westbury, H. A., And Smith, J. S., Polymerase chain reaction and other laboratory techniques in the diagnosis of long incubation periods in Australia, Aust. Vet. J. 70: 84–89 (1993).
Mebatsion, T., Cox, J. H., And Frost, J. W., Isolation and characterization of 115 street rabies virus isolates from Ethiopia by using monoclonal antibodies: Identification of 2 isolates as Mokola and Lagos bat viruses, J. Infect. Dis. 166: 972–977 (1992).
Meslin, F. X., Fishbein, D. B., And Matter, H. C., Rationale and prospects for rabies elimination in developing countries, in: Lyssaviruses (C. E. Rupprecht, B. Dietzschold, And H. KoProwski, Eds.), pp. 1–26, Springer-Verlag, New York, 1994.
Montano-Hirose, J. A., Lafage, M., Weber, R, Badrane, H., ToRDo, N., And Lapon, M., Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (Ebv1) infection in mice, Vaccine 11: 1259–1266 (1993).
Nyberg, M., Kulonen, K., Neuvonen, E., EK, K. C., Nuorgam, M., And Westerling, B., An epidemic of sylvatic rabies in Finland-Descriptive epidemiology and results of oral vaccination, Acta Vet. Scand. 33: 43–57 (1992).
Orr, R. H., Rubin, M. R., And Aoki, F. Y., Naturally acquired serum rabies neutralizing antibody in a Canadian Inuit population, Arctic Med. Res. 47 (Suppl. 1): 699–700 (1988).
Pacer, R. E., Fishbein, D. B., Baer, G. M., Jenkins, S. R., And Smith, J. S., Rabies in the United States and Canada, 1983, Morbid. Mortal. Week. Rep. 34:11SS–27SS (1985).
Palmer, D. G., Ossent, R, Suter, M. M., And Ferrari, E., Demonstration of rabies virus antigen in paraffin tissue sections: Comparison of the immunofluorescence technique with the unlabeled antibody enzyme method, Am. J. Vet. Res. 46: 283–286 (1985).
Pastoret, P. R, Brochier, B., Languet, B., Thomas, I., Paquot, A., Bauldain, B., Kieny, M. R, Lecocq, J. R, Debruyn, J., CoSty, F., Antoine, H., And DesmerrRE, R, First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus, Vet. Rec. 123: 481–483 (1988).
Pearlman, E. S., And Ballas, S. K., False-positive human immunodeficiency virus screening test related to rabies vaccination, Arch. Pathol. Lab. Med. 118: 805–806 (1994).
PoRras, C., Barboza, J. J., Fuenzalida, E., Adaros, H. L., Oviedo, A. M., And Furst, J., Recovery from rabies in man, Ann. Intern. Med. 85: 44–48 (1976).
Prehaud, C., Takehanak, K., Flamand, A., And Bishop, D. H. L., Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors, Virology 173: 390399 (1989).
Prevec, L., Campbell, J. B., Christie, B. S., Belbeck, L., And Graham, F. L., A recombinant human adenovirus vaccine against rabies, J. Infect. Dis. 161: 27–30 (1990).
Rando, R. F., And NoTkins, A. L., Production of human monoclonal antibodies against rabies virus, Curr. Topics Microbiol. Immun. 187: 195–205 (1994).
Reid, F. L., Hall, H. N., Smith, J. S., And Baer, G. M., Increased immunofluorescence staining of rabies-infected, formalin-fixed brain tissue after pepsin and trypsin digestion, J. Clin. Microbiol. 18: 968–971 (1983).
Revilia, L., Phssara, E, Ormaecho, M., Volande, J., Rodriguez, A., Rupprecht, C., Choy, M., And Sniadack, D., Survival from rabies infection in the Peruvian jungle, 1994, Field Epidemiology Training Program Scientific Conference Abstract, Centers for Disease Control and Prevention, Atlanta, GA, 24 March 1995, p. 38.
RosArrE, R. C., Howard, D. R., Campbell, J. B., And Macinnes, C. D., Intramuscular vaccination of skunks and raccoons against rabies, J. Wildl. Dis. 26: 225–230 (1990).
Rosner, F., Rabies in the Talmud, Med. Hist. 18: 198–200 (1974).
Rudd, R. J., And Trimarci-II, C. V., Development and evaluation of an in vitro virus isolation procedure as a replacement for the mouse inoculation test in rabies diagnosis, J. Clin. Microbiol. 27: 2522–2528 (1989).
Rupprecht, C. E., Wiktor, T. J., Johnston, D. H., Hamir, A. N., Dietzschold, B., Wunner, W. H., Glickman, L. T., And Koprowski, H., Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine, Proc. Natl. Acad. Sci. Usa 83: 7947–7950 (1986).
Rupprecht, C. E., And Dietzschold, B., Perspectives on rabies virus pathogenesis, Lab. Invest. 57: 603–606 (1987).
Rupprecht, C. E., Hamir, A. N., Johnston, D. H., And KoProwski, H., Efficacy of vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor), Rev. Infect. Dis. 10: S803–809 (1988).
Rupprecht, C. E., Dietzschold, B., Wunner, W. H. And Koprowski, H., Antigenic relationships of lyssaviruses, in: The Natural History of Rabies (G. M. Baer, ED.), pp. 69–100, Crc Press, Boca Raton, FL, 1991.
Rupprecht, C. E., Dietzschold, B., Campbell, J. B., Charlton, K. M., And Koprowski, H., Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores, J. Wildl. Dis. 28: 629–635 (1992).
Rupprecht, C. E., Hanlon, C. A., Hamir, A. N., And KoProwski, H., Oral wildlife rabies vaccination: Development of a recombinant virus vaccine, in: Transactions of the 57th North American Wildlife and Natural Resources Conference-1992 (R. E. McCabe, ED.), pp. 439–452, Washington, DC, Wildlife Management Institute, 1992.
Rupprecht, C. E., And Smith, J. S., Raccoon rabies: The emergence of an epizootic in a densely populated area, Semin. Virol. 5: 155–164 (1994).
Rupprecht, C. E., Shankar, V., Hanlon, C. A., Hamir, A., And Koprowski, H., Beyond Pasteur to 2001: Future trends in lyssavirus research? in: Lyssaviruses (C. E. Rupprecht, B. Dietzschold, And H. Koprowski, Eds.), pp. 325–340, Springer-Verlag, New York, 1994.
Sacramento, D., Bourhy, H., And ToRdo, N., Pcr technique as an alternative method for diagnosis and molecular epidemiology of rabies virus, Mol. Cell. Probes 5: 229–240 (1991).
Schneider, L. G., Spread of virus within the central nervous system, in: The Natural History of Rabies (G. M. Baer, ED.), pp. 199–216, Academic Press, New York, 1975.
Schnell, M. J., Mebatsion, T., And Conzelmann, K. K., Infectious rabies viruses from cloned cDna, Embo J. 13: 41954203 (1994).
Schumacher, C. L., Dietzschold, B., Ertl, H. C., Niu, H. S., Rupprecht, C. E., And Koprowski, H., Use of mouse antirabies monoclonal antibodies in postexposure treatment of rabies, J. Clin. Invest. 84: 971–975 (1989).
Schumacher, C., Ertl, H., Koprowski, H., And Dietzschold, B., Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens, Vaccine 10: 754–760 (1992).
Shankar, V., Dietzschold, B., And Koprowski, H., Direct entry of rabies virus into the central nervous system without prior local replication, J. Virol. 65: 2736–2738 (1991).
Smart, N. L., And Charlton, K. M., The distribution of challenge virus standard rabies virus versus skunk street rabies virus in the brains of experimentally infected rabid skunks, Acta Neuropathol. 84: 501–508 (1992).
Smith, G. L., Virus strategies for evasion of the host response to infection, Trends Microbiol. 2: 81–88 (1994).
Smith, J. S., Rabies serology, in: The Natural History of Rabies, 2nd ed. (G. M. Baer, ED.), pp. 235–254, Crc Press, Boca Raton, FL, 1991.
Smith, J. S., Rabies virus, in: Manual of Clinical Microbiology, 6th ed., (P. R. Murray ET All., Ens.), pp. 997–1003, Asm Press, Washington, DC, 1995.
Smith, J. S., Fishbein, D. B., Rupprecht, C. E., And Clark, K., Unexplained rabies in three immigrants in the United States, N. Engl. J. Med. 324:205–211 (1991).
Smith, J. S., Orciari, L. A., Yager, P. A., Seidel, H. D., And Warner, C. K., Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis, J. Infect. Dis. 166:296–307 (1992).
Smith, J. S., And Seidel, H. D., Rabies: A new look at an old disease, in: Progress in Medical Virology (J. L. Melnick, ED.), pp. 82–106, Karger, Basel, 1993.
Steele, J. H., And Fernandez, P. J., History of rabies and global aspects, in: The Natural History of Rabies (G. M. Baer, ED.), pp. 1–24, Crc Press, Boca Raton, FL, 1991.
Sugamata, M., Miyazawa, M., Mori, S., Sprangrude, G. J., Ewalt, L. C., And Lodmell, D. L., Paralysis of street rabies virus-infected mice is dependent on T lymphocytes, J. Virol. 66: 1252–1260 (1992).
Tartaglia, J., Perkus, M. E., Taylor, J., Norton, E. K., Audonnet, J. C., Cox, W. I., Davis, S. W., Vanderhoeven, J., Meignier, B., Riviere, M., Languet, B., And Paoletti, E., Nyvac: A highly attenuated strain of vaccinia virus, Virology 188: 217–232 (1992).
Taylor, J., Weinberg, R., Languet, B., Desmettre, P., And Paoletti, E., A recombinant fowlpox virus induces protective immunity in non-avian species, Vaccine 6: 497–503 (1988).
Taylor, J., Trimarchi, C., Weinberg, R., Languet, B., Gun.w imi, F Desmettre, P, And Paoletti, E., Efficacy studies on a canarypox-rabies recombinant virus, Vaccine 9: 190–193 (1991).
Thomas, I., Brochier, B., Languet, B., Blancou, J., Peharpre, D., Kieny, M. P., Desmettre, P., Chappuis, Q., And Pastoret, P. P., Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route, J. Gen. Viral. 71: 37–42 (1990).
Thraenhart, O., Marcus, I., And Kreuzfelder, E., Current and future immunoprophylaxis against human rabies: Reduction of treatment failures and errors, Curr. Topics Microbiol. Immun. 187: 173–194 (1994).
Tollis, M., Dietzschold, B., Volta, C. B., And Koprowski, H., Immunization of monkeys with rabjes ribonucleoprotein (Rnp) confers protective immunity against rabies, Vaccine 9: 134–136 (1991).
Tolson, N. D., Charlton, K. M., Stewart, R. B., Campbell, J. B., And Wiktor, T. J., Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein, Can. J. Vet. Res. 52: 363–366 (1987).
ToLsoN, N. D., Charlton, K. M., Casey, G. A., Knowles, M. K., Rupprecht, C. E., Lawson, K. F., And Campbell, J. B., Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein, Arch. Virol. 102: 297301 (1990).
TsIang, H., Pathophysiology of rabies virus infection of the nervous system, Adv. Virus Res. 42: 375–412 (1993).
Tuchiya, K., Matsuura, Y., Kawai, A., Ishihama, A., And Ueda, S., Characterization of rabies virus glycoprotein expressed by recombinant baculovirus, Virus. Res. 25: 1–13 (1992).
Uhaa, I. J., Dato, V. M., Sorhage, E E., Beckley, J. W., RoscoE, D. E., Gorsky, R. D., And Fishbein, D. B., Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons, J. Am. Vet. Med. Assoc. 201:1873–1882 (1992).
Wandeler, A. I., Oral immunization of wildlife, in: The Natural History of Rabies (G. M. Baer, ED.), pp. 485–503, Crc Press, Boca Raton, FL, 1991.
Wandeler, A. I., Matter, H. C., Kappeler, A., And Budde, A., The ecology of dogs and canine rabies: A selective review, Rev. Sci. Tech. 12: 51–71 (1993).
Wandeler, A. I., Nadin-Davis, S. A., Tinline, R. R., And Rupprecht, C. E., Rabies epidemiology: Some ecological and evolutionary perspectives, in: Lyssaviruses (C. E. Rupprecht, B. Dietzschold, And H. Koprowski, Eds.), pp. 297–324, Springer-Verlag, New York, 1994.
Wiktor, T. J., Macfarlan, R. I., Reagan, K. J., Dietzschold, B. D., Culrns, P. J., Wunner, W. H., Kieny, M.-P., Lathe, R., Lecocq, J., Mackett, M., Moss, 13., And Koprowski, H., Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene, Proc. Natl. Acad. Sci. Usa 81: 7194–7198 (1984).
Wiktor, T. J., Macfarlan, R. I., Dietzschold, B., Rupprecht, C. E., And Wunner, W. H., Immunogenic properties of vaccinia recombinant virus expressing the rabies glycoprotein, Ann. Irlst. Past./Virol. 136E: 405–411 (1985).
Wiktor, T. J., Historical aspects of rabies treatment, in: World’s Debt to pasteur (H. Koprowski And S. Plotkin, Ems.), pp. 141151, Liss, New York, 1985.
Wiktor, T. J., Sokol, E, Kuwert, E., And Koprowski, H., Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin, Proc. Soc. Exp. Biol. Med. 1.31: 799–805 (1975).
Wilde, H., Chomchey, P., Punyaratabandhu, P., Phanupak, P., And Chutivongse, S., Purified equine rabies immune globulin: A safe and affordable alternative to human rabies immune globulin, Bull. Who 67: 731–736 (1989).
Wilde, H., Chomchey P., Prakongsri, S., Puyaratabandhu, P., And Chutivongse, S., Adverse effects of equine rabies immune globulin, Vaccine 7: 10–11 (1989).
Wilde, H., And Chutivongse, S., Equine rabies immune globulin: A product with an undeserved poor reputation, Am. J. Trop. Med. Hyg. 42: 175–178 (1990).
Wilkinson, L., The development of the virus concept as reflected in corpora of studies on individual pathogens: Rabies—Two millennia of ideas and conjecture of the aetiology of a virus disease, Med. Hist. 21: 15–31 (1977).
Winkler, W. G., Fashinell, T. R., Leffingwell, L., Howard, P., And Conomy, P., Airborne rabies transmission in a laboratory worker, J.A.M.A. 226: 1219–1221 (1973).
World Health Organization, Who Expert Committee On Rabies-8th report, World Health Organ. Tech Rep. Ser. 824: 184 (1992).
World Health Organization, Two rabies cases following corneal transplantation, Week. Epidemiol. Rec. 69: 330 (1994).
World Health Organization, Report of the 5th consultation on oral immunization of dogs against rabies, Geneva, 20–22 June, 1994, pp. 1–24.
World Health Organization, Oral immunization of foxes in Europe in 1994, Week. Epidemiol. Rec. 70: 89–91 (1995).
World Health Organization, World Survey of Rabies 28 for Year 1992, Geneva, 1994, pp. 1–24.
Wunner, W. H., The chemical composition and molecular structure of rabies viruses, in: The Natural History of Rabies, 2nd ed. (G. M. Baer, ED.), pp. 31–67, Crc Press, Boca Raton, FL, 1991.
Xiang, Z. W., Spitalnik, S., Tran, M., Wunner, W. H., Cheng, J., And Ertl, H. C., Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus, Virology 199: 132–140 (1994).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rupprecht, C.E., Hanlon, C.A. (1997). Rabies. In: Evans, A.S., Kaslow, R.A. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0036-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0036-4_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44856-0
Online ISBN: 978-1-4899-0036-4
eBook Packages: Springer Book Archive